FOCUS Investment Banking Represents aeSolutions in the sale of its Division, aeCyberSolutions, to Deloitte Risk & Financial Advisory
Washington, DC, (August 9, 2021) – FOCUS Investment Banking (“FOCUS”), a national mid- dle market investment banking firm providing merger, acquisition, divestiture... Read more.
FOCUS Investment Banking Represents Sage Management in its Acquisition by SIB Fixed Cost Reduction
Washington, DC, (August 9, 2021) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture... Read more.
FOCUS U.S. Communications Service Provider Quarterly: Summer 2021 Report
Public Markets
The FOCUS Communications Service Provider Index (CSPI) was barely in the black for this current period with a three-month gain of 1.0%.This lagged... Read more.
FOCUS Telecom Business Services Quarterly: Summer 2021 Report
Public Markets
Once again, the FOCUS Telecom Business Services Index (TBSI) climbed higher, gaining 3.5% over the past three months. This marks the fifth straight... Read more.
ENT & Allergy Report – Q2 2021 Acquisition Activity and Outlook
Quiet Quarter for ENT & Allergy Practices Acquisitions. Expect Increasing Opportunity for Large Practice Sellers
Although we did not track any reported transactions... Read more.
Dermatology Report – Q2 2021 Acquisition Activity and Outlook
Core Dermatology Buyers Remain Active in 2021. Window of Opportunity May Be Starting to Close for Smaller Practices
The second quarter of 2021 delivered six reported... Read more.
Behavioral Health Report – Q2 2021 Acquisition Activity and Outlook
Transaction Volume Remains High Throughout Behavioral Health
The second quarter of 2021 delivered thirty-four reported behavioral health transactions, continuing... Read more.
Women’s Health Report – Q2 2021 Acquisition Activity and Outlook
Women’s Health Deals Dip in Q2. Expect Resurgence by End of Year
Partners Group recaps Axia. The second quarter of 2021 delivered one reported Women's Health practice... Read more.
Urology Report – Q2 2021 Acquisition Activity and Outlook
Quiet Quarter for Urology Practice Acquisitions. Increase Expected for Second Half of 2021
The second quarter of 2021 delivered one reported urology practice acquisitions,... Read more.
Orthopedics Report – Q2 2021 Acquisition Activity and Outlook
Orthopedic Platforms Continue to Form - Positioning for Market Share and Private Equity Recapitalization
The second quarter of 2021 delivered three reported orthopedic... Read more.
Ophthalmology Report – Q2 2021 Acquisition Activity and Outlook
After a Strong First Half, 2021 Is Now Looking Like a True Window of Opportunity for Ophthalmology Deals
The second quarter of 2021 delivered twenty-two reported... Read more.
Home Health & Hospice Report – Q2 2021 Acquisition Activity and Outlook
Transaction Volume Continues to Increase Across Home Health & Hospice The second quarter of 2021 delivered 40 reported home health and hospice transactions continuing... Read more.
Gastroenterology Report – Q2 2021 Acquisition Activity and Outlook
Gastroenterology Acquisition Activity Remains High in Q2 2021 – Major Opportunity for Selling Physicians
The second quarter of 2021 delivered eight gastroenterology... Read more.
FOCUS Investment Banking featured in Axial’s 2021 Business Services Top 50
Washington, DC, (July 22, 2021) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture,... Read more.
FOCUS Investment Banking Represents Mahansaria Tyres Private Limited in its Acquisition of Tyres International
Washington, DC, (July 15, 2021) – Washington, DC, (July 15, 2021) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm... Read more.